Psilocybin and its effects on memory and brain function
Treatments studied
This trial tests how psilocybin, a psychedelic substance, affects your thinking, memory, and brain activity. Researchers want to understand these effects in healthy adults who have used psychedelics before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 45 years old.
- You have used psychedelics 3 to 30 times in your life.
- English is your first language.
- You have a high school education or equivalent.
- You are mentally and physically healthy, as confirmed by a medical check-up.
- Your body mass index (BMI) is between 19 and 30.
- You are right-handed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.
This study tests how psilocybin (the active ingredient in magic mushrooms) affects consciousness by blocking a specific serotonin receptor in the brain. It helps researchers understand why psilocybin causes altered states of mind.
This trial tests whether taking pimavanserin before psilocybin changes the drug's effects in healthy volunteers who have never used psychedelics. It aims to understand how to make psychedelic therapy safer and more predictable.
This study compares how three different psychedelic substances affect your state of mind. The goal is to better understand these altered states, which may help develop future treatments.
This study tests whether very small, repeated doses of psilocybin (a substance found in certain mushrooms) can improve thinking, mood, and quality of life. It is for adults who have never used psychedelics and are in good general health, both mentally and physically.
This study gives a single dose of psilocybin to healthy adults who are curious about psychedelics but have little to no past use. Researchers will measure how it affects your mood, brain activity, and body chemistry to understand its effects better.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.